We're dedicated to providing safe and effective medicines, alongside services and support for healthy outcomes. This involves superior science, creativity, and collaboration with stakeholders at all levels. As a leading pharma company in the U.S., we focus on devastating diseases and complex medical challenges across six specific therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
The Therapeutic Giving program from Janssen supports initiatives and programs that aim to improve patient access to treatment and services, advance health equity, and strengthen frontline health workforces within their identified therapeutic areas. Prioritized are efforts that contribute to health system improvement with measurable outcomes, rather than fundraising activities. The program specifically backs initiatives focused on disease awareness, patient empowerment and advocacy, and facilitating connections to care. Particular areas of interest within the Cardiovascular therapeutic area include stroke prevention in certain populations, risk management for Thromboembolic Disease and Vascular Protection to prevent amputation. The grant supports education for patients and caregivers, family and caregiver wellness and advocacy, innovative patient self-management efforts, anti-coagulant therapy assistance tools, professional and caregiver skill-building to enhance patient outcomes, and addressing healthcare disparities and advocacy for access to care among marginalized or at-risk groups.